Literature DB >> 11261321

Increased susceptibility of a carrier of X-linked chronic granulomatous disease (CGD) to Aspergillus fumigatus infection associated with age-related skewing of lyonization.

A Rösen-Wolff1, W Soldan, K Heyne, J Bickhardt, M Gahr, J Roesler.   

Abstract

Chronic granulomatous disease (CGD) is an inherited disorder characterized by the inability of phagocytes to generate normal amounts of superoxide (O2-), leaving patients susceptible to life-threatening infections. It was previously assumed that once carriers of the X-linked form of CGD were found to have 30% or more of functionally normal neutrophils, they would be free of risk for infection because the lyonization ratio was believed to be constant. Our report strongly contradicts this assumption. A 45-year-old X-CGD carrier had approximately 40% of normal neutrophils in her peripheral blood at age 21 years. Recently, she contracted a life-threatening pulmonary infection with Aspergillus fumigatus. After recovery, the ratio of normal-to-nonfunctional neutrophils was re-evaluated. She was found to have only 6-8% of normal neutrophils, suggesting that a striking decrease in the number of normal cells over the past 25 years was the reason for an increased susceptibility to Aspergillus infection. We conclude that age-related acquired skewing of the lyonization ratio can result in an increased susceptibility to life-threatening infections in X-CGD carriers.

Entities:  

Mesh:

Year:  2001        PMID: 11261321     DOI: 10.1007/s002770000230

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  23 in total

Review 1.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

Review 2.  Chronic granulomatous disease.

Authors:  Steven M Holland
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

Review 3.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

4.  A 60-year-old asymptomatic woman with pulmonary lesions and cervical lymphadenopathy.

Authors:  Tomoko Yamagishi; Nobuaki Ochi; Hiromichi Yamane; Futoshi Kuribayashi; Nagio Takigawa
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

5.  Assessment of atherosclerosis in chronic granulomatous disease.

Authors:  Christopher T Sibley; Tyra Estwick; Anna Zavodni; Chiung-Yu Huang; Alan C Kwan; Benjamin P Soule; Debra A Long Priel; Alan T Remaley; Amanda K Rudman Spergel; Evrim B Turkbey; Douglas B Kuhns; Steven M Holland; Harry L Malech; Kol A Zarember; David A Bluemke; John I Gallin
Journal:  Circulation       Date:  2014-09-19       Impact factor: 29.690

Review 6.  The role of interleukin-1 family members in the host defence against Aspergillus fumigatus.

Authors:  Mark S Gresnigt; Frank L van de Veerdonk
Journal:  Mycopathologia       Date:  2014-07-22       Impact factor: 2.574

7.  X-chromosome inactivation analysis in a female carrier of FOXP3 mutation.

Authors:  A Tommasini; S Ferrari; D Moratto; R Badolato; M Boniotto; D Pirulli; L D Notarangelo; M Andolina
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

8.  The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review.

Authors:  Rohan Ameratunga; See-Tarn Woon; Katherine Neas; Donald R Love
Journal:  Allergy Asthma Clin Immunol       Date:  2010-06-08       Impact factor: 3.406

Review 9.  Chronic granulomatous disease.

Authors:  Steven M Holland
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-22       Impact factor: 3.722

10.  Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan.

Authors:  Shinichi Kobayashi; Shizuko Murayama; Sayaka Takanashi; Kumiko Takahashi; Sachiko Miyatsuka; Tomoko Fujita; Sadato Ichinohe; Yuichi Koike; Toshitaka Kohagizawa; Hirosumi Mori; Yasushi Deguchi; Kaoru Higuchi; Hiroaki Wakasugi; Tatsuya Sato; Yasuyuki Wada; Masato Nagata; Nobuhiko Okabe; Osamu Tatsuzawa
Journal:  Eur J Pediatr       Date:  2008-03-12       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.